METC heads into today's earnings with one of the most charged short-side setups in the small-cap materials space — nearly 23% of the free float bet against it, options pricing a rare defensive spike, and borrow availability at its tightest level of the past year.
The short positioning here is genuinely extreme. At 23% of free float, short interest has climbed roughly 7% over the past month and carries a days-to-cover reading above nine — meaning shorts would need almost two full trading weeks to unwind at average volume. The ORTEX short score of 78.1 has held near that elevated level for weeks, ranking METC in the bottom percentile of the universe on both days-to-cover and utilization factors. More telling is the direction of the lending market: availability has collapsed to just 28.8% — the lowest reading of the past 52 weeks — down sharply from above 70% only a week ago. That means for every share currently borrowed short, fewer than a third of a share remains available for new positions. Borrow cost, at 0.68%, has risen 33% over the past month, though it remains technically cheap — the tighter availability is the more important signal here.
Options positioning amplified that caution sharply on the day before the print. The put/call ratio jumped to 0.47 — more than three standard deviations above its 20-day average of 0.24. That is a dramatic one-session re-rating: for most of July the ratio barely exceeded 0.30. Investors went from running one of the most call-heavy books of the year to loading up on downside protection in a single day. The stock itself bounced 8.3% on August 4, clawing back some of a brutal month — METC has shed 25.6% over the past 30 days to close at $9.64. Closest peers and slipped roughly 5% and flat on the week respectively, suggesting METC's drawdown has a company-specific component beyond sector pressure.
The analyst debate is tilted toward caution, with the most recent moves from bellwether firms pointing firmly lower. Goldman Sachs cut its target to $13 in early July, maintaining Neutral. Morgan Stanley trimmed to $13 at roughly the same time, from $17 previously. Both cuts arrived against a backdrop of weak fundamentals — a Piotroski F-score of just 1, negative return on assets, and a sales line down 17% year-on-year. Bulls point to the gap between price and consensus: the mean analyst target of $24.63 implies more than 150% upside from current levels, and B. Riley and Baird both retain positive ratings despite trimming targets earlier in the year. The company also ranks in the 83rd percentile on EPS surprise history, suggesting a better-than-expected print is structurally plausible. Bears counter that the price-to-book multiple has compressed to 1.37x and trending lower, earnings are currently negative, and the stock's Altman Z-score sits in the grey zone.
The print today will test whether METC's operational results can justify any recovery from a stock that has been cut in half on the year — or whether a high-short-interest, low-availability setup in a fundamentally pressured name becomes the catalyst for further unwinding.
See the live data behind this article on ORTEX.
Open METC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
